Table 3.
Outcome (mortality) in TTS patients
| Variables | No catecholamines (n = 93) |
catecholamines
(n = 21) |
Relative risk (95% CI) | p value * |
|---|---|---|---|---|
| In-hospital mortality | 3 (3.22) | 6 (28.57) | (1.0–6.5) | < 0.01 |
| 30-day mortality | 3 (2.15) | 6 (28.57) | (1.0–6.5) | < 0.01 |
| 1-year mortality | 6 (6.45) | 8 (38.09) | (1.1–3.7) | < 0.01 |
| 2-year mortality | 11 (11.82) | 10 (47.61) | (1.1–2.5) | < 0.01 |
| 3-year mortality | 12 (12.90) | 11 (52.38) | (1.1–2.5) | < 0.01 |
| 4-year mortality | 18 (19.35) | 11 (52.38) | (1.0–1.9) | < 0.01 |
| Long-term mortality | 20 (21.50) | 13 (61.90) | (1.1–2.0) | < 0.01 |
*p values for the comparison between no catecholamines and catecholamines